Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer
Brittney S. Harrington(Translational Research Institute), John D. Hooper(Mater Research)
Cited by 31
Related Papers
Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
|British Journal of Cancer|2016|82
The Role of Palmitoylation in Signalling, Cellular Trafficking and Plasma Membrane Localization of Protease-Activated Receptor-2
|PLoS ONE|2011|52
Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer
|Contrast Media & Molecular Imaging|2021|5
Cellular Settings Mediating Src Substrate Switching between Focal Adhesion Kinase Tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) Tyrosine 734
|Journal of Biological Chemistry|2011|4
Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKC?
|QUT ePrints (Queensland University of Technology)|2010|1